Detalhe da pesquisa
1.
Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer.
N Engl J Med
; 388(6): 489-498, 2023 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36780674
2.
TOX is a critical regulator of tumour-specific T cell differentiation.
Nature
; 571(7764): 270-274, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31207604
3.
A Unique Cellular Organization of Human Distal Airways and Its Disarray in Chronic Obstructive Pulmonary Disease.
Am J Respir Crit Care Med
; 207(9): 1171-1182, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36796082
4.
Extended Lymphadenectomy Improves Survival After Induction Chemoradiation for Esophageal Cancer: A Propensity-Matched Analysis of the National Cancer Database.
Ann Surg
; 277(4): e772-e776, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34475320
5.
Ten-Year Survival and Recurrence Patterns After Three-Field Lymph Node Dissection for Squamous Cell and Adenocarcinoma of the Esophagus.
Ann Surg
; 278(1): e43-e50, 2023 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35866662
6.
A 20-year Follow-up of the International Early Lung Cancer Action Program (I-ELCAP).
Radiology
; 309(2): e231988, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37934099
7.
Proximity proteome mapping reveals PD-L1-dependent pathways disrupted by anti-PD-L1 antibody specifically in EGFR-mutant lung cancer cells.
Cell Commun Signal
; 21(1): 58, 2023 03 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36915197
8.
Surgical Treatment at an Academic Medical Center is Associated with Statistically Insignificant Lung Cancer Survival Outcome Differences Related to ZIP Code.
World J Surg
; 47(8): 2052-2064, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37046063
9.
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial.
Lancet
; 398(10308): 1344-1357, 2021 10 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34555333
10.
CUL4high Lung Adenocarcinomas Are Dependent on the CUL4-p21 Ubiquitin Signaling for Proliferation and Survival.
Am J Pathol
; 191(9): 1638-1650, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34119472
11.
Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial.
Lancet Oncol
; 22(6): 824-835, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34015311
12.
Validation of a Circulating Tumor DNA-Based Next-Generation Sequencing Assay in a Cohort of Patients with Solid tumors: A Proposed Solution for Decentralized Plasma Testing.
Oncologist
; 26(11): e1971-e1981, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34286887
13.
Extent of Surgery for Stage IA Non-Small-Cell Lung Cancer. Reply.
N Engl J Med
; 388(17): 1629-1630, 2023 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37099350
14.
Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance.
Nature
; 527(7579): 472-6, 2015 Nov 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-26560033
15.
Sensitivity and specificity of fine needle aspiration for the diagnosis of mediastinal lesions.
Ann Diagn Pathol
; 39: 69-73, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30797131
16.
Fischer et al. reply.
Nature
; 547(7661): E5-E6, 2017 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28682327
17.
Lung inflammation promotes metastasis through neutrophil protease-mediated degradation of Tsp-1.
Proc Natl Acad Sci U S A
; 112(52): 16000-5, 2015 Dec 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-26668367
18.
Computed Tomography Screening for Lung Cancer: Mediastinal Lymph Node Resection in Stage IA Nonsmall Cell Lung Cancer Manifesting as Subsolid and Solid Nodules.
Ann Surg
; 265(5): 1025-1033, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27232256
19.
p53Ψ is a transcriptionally inactive p53 isoform able to reprogram cells toward a metastatic-like state.
Proc Natl Acad Sci U S A
; 111(32): E3287-96, 2014 Aug 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-25074920
20.
Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 17(6): 822-835, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27132212